The US Food and Drug Administration (FDA) has approved the Hydrus Microstent, a device used for microinvasive glaucoma surgery (MIGS) in patients with mild to moderate primary open-angle glaucoma, in conjunction with cataract surgery.
YOUR SOURCE FOR THE BEST ASSISTIVE TECH NEWS, REVIEWS AND INTERVIEWS FROM TOP BLIND AND LOW VISION EXPERTS. AN ENTERTAINING AND TRUSTWORTHY DISCUSSION ON EMERGING TECHNOLOGIES
You must be logged in to post a comment.